|
1
|
Salah HT, D'Ardis JA, Baek D, Duran J,
Schwartz MR, Ayala AG and Ro JY: Case of recurrent superficial
CD34-positive fibroblastic tumor. J Cutan Pathol. 50:477–480. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Carter JM, Weiss SW, Linos K, DiCaudo DJ
and Folpe AL: Superficial CD34-positive fibroblastic tumor: Report
of 18 cases of a distinctive low-grade mesenchymal neoplasm of
intermediate (borderline) malignancy. Mod Pathol. 27:294–302. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
WHO Classification of Tumours, . Soft
Tissue and Bone Tumours. IARC Press; France: 2020
|
|
4
|
Salah HT, D'ardis JA, Baek D, Schwartz MR,
Ayala AG and Ro JY: Superficial CD34-positive fibroblastic tumor
(SCPFT): A review of pathological and clinical features. Ann Diagn
Pathol. 58:1519372022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Anderson WJ, Mertens F, Mariño-Enríquez A,
Hornick JL and Fletcher CD: Superficial CD34-positive fibroblastic
tumor: A clinicopathologic, immunohistochemical, and molecular
study of 59 cases. Am J Surg Pathol. 46:1329–1339. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li W, Molnar SL, Mott M, White E and De
Las Casas LE: Superficial CD34-positive fibroblastic tumor:
Cytologic features, tissue correlation, ancillary studies, and
differential diagnosis of a recently described soft tissue
neoplasm. Diagn Cytopathol. 44:926–930. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lao IW, Yu L and Wang J: Superficial
CD34-positive fibroblastic tumour: A clinicopathological and
immunohistochemical study of an additional series. Histopathology.
70:394–401. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Perret R, Michal M, Carr RA, Velasco V,
Švajdler M, Karanian M, Meurgey A, Paindavoine S, Soubeyran I,
Coindre JM, et al: Superficial CD34-positive fibroblastic tumor and
PRDM10-rearranged soft tissue tumor are overlapping entities: A
comprehensive study of 20 cases. Histopathology. 79:810–825. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sood N and Khandelia BK: Superficial
CD34-positive fibroblastic tumor: A new entity; case report and
review of literature. Indian J Pathol Microbiol. 60:377–380. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rekhi B, Banerjee D, Gala K and Gulia A:
Superficial CD34-positive fibroblastic tumor in the forearm of a
middle-aged patient: A newly described, rare soft-tissue tumor.
Indian J Pathol Microbiol. 61:421–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hamada T, Katsuki N, Hosokawa Y, Ayano Y
and Ikeda M: Additional case of superficial CD34-positive
fibroblastic tumor in a Japanese patient. J Dermatol. 46:e134–e136.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Batur S, Ozcan K, Ozcan G, Tosun I and
Comunoglu N: Superficial CD34 positive fibroblastic tumor: Report
of three cases and review of the literature. Int J Dermatol.
58:416–422. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ding L, Xu WJ, Tao XY, Zhang L and Cai ZG:
Clinicopathological features of superficial CD34-positive
fibroblastic tumor. World J Clin Cases. 9:2739–2750. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li SY, Zhang HL and Bai YZ: Superficial
CD34-positive fibroblastic tumor on the chest wall of an 8-year-old
girl: A case report and literature review. Pediatr Hematol Oncol.
38:602–608. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mao X, Sun YY, Deng ML, Ma T and Yu L:
Superficial CD34-positive fibroblastic tumor: Report of two cases
and review of literature. Int J Clin Exp Pathol. 13:38–43.
2020.PubMed/NCBI
|
|
16
|
Andrei V, Haefliger S and Baumhoer D:
Superficial mesenchymal tumours expressing epithelial markers on
immunohistochemistry: Diagnostic clues and pitfalls. Semin Diagn
Pathol. 40:238–245. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Puls F, Carter JM, Pillay N, McCulloch TA,
Sumathi VP, Rissler P, Fagman H, Hansson M, Amary F, Tirabosco R,
et al: Overlapping morphological, immunohistochemical and genetic
features of superficial CD34-positive fibroblastic tumor and
PRDM10-rearranged soft tissue tumor. Mod Pathol. 35:767–776. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hofvander J, Tayebwa J, Nilsson J,
Magnusson L, Brosjö O, Larsson O, von Steyern FV, Mandahl N,
Fletcher CD and Mertens F: Recurre2nt PRDM10 gene fusions in
undifferentiated pleomorphic sarcoma. Clin Cancer Res. 21:864–869.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao M, Yin X, He H, Fan Y, Ru G and Meng
X: Recurrent PRDM10 fusions in superficial CD34-positive
fibroblastic tumors: A clinicopathologic and molecular study of 10
additional cases of an emerging novel entity. Am J Clin Pathol.
159:367–378. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rayyan MM, Aboushelib M, Sayed NM, Ibrahim
A and Jimbo R: Comparison of interim restorations fabricated by
CAD/CAM with those fabricated manually. J Prosthet Dent.
114:414–419. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kaddu S, McMenamin ME and Fletcher CD:
Atypical fibrous histiocytoma of the skin: Clinicopathologic
analysis of 59 cases with evidence of infrequent metastasis. Am J
Surg Pathol. 26:35–46. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Michal M, Kazakov DV, Hadravský L, Agaimy
A, Švajdler M, Kuroda N and Michal M: Pleomorphic hyalinizing
angiectatic tumor revisited: All tumors manifest typical
morphologic features of myxoinflammatory fibroblastic sarcoma,
further suggesting 2 morphologic variants of a single entity. Ann
Diagn Pathol. 20:40–43. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gru AA and Cruz DJ: Atypical
fibroxanthoma: A selective review. Semin Diagn Pathol. 30:4–12.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kohashi K, Yamada Y, Hotokebuchi Y,
Yamamoto H, Taguchi T, Iwamoto Y and Oda Y: ERG and SALL4
expressions in SMARCB1/INI1-deficient tumors: A useful tool for
distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Hum Pathol. 46:225–230. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kodera K, Hoshino M, Takahashi S, Hidaka
S, Kogo M, Hashizume R, Imakita T, Ishiyama M, Ogawa M and Eto K:
Surgical management of primary undifferentiated pleomorphic sarcoma
of the rectum: A case report and review of the literature. World J
Surg Oncol. 20:1992022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ríos-Viñuela E, Serra-Guillén C, Llombart
B, Requena C, Nagore E, Traves V, Guillén C, Vázquez D and
Sanmartín O: Pleomorphic dermal sarcoma: A retrospective study of
16 cases in a dermato-oncology centre and a review of the
literature. Eur J Dermatol. 30:545–553. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ieremia E and Thway K: Myxoinflammatory
fibroblastic sarcoma: Morphologic and genetic updates. Arch Pathol
Lab Med. 138:1406–1411. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Díaz-Flores L, Gutiérrez R, García MP,
Sáez FJ, Díaz-Flores L Jr, Valladares F and Madrid JF: CD34+
stromal cells/fibroblasts/fibrocytes/telocytes as a tissue reserve
and a principal source of mesenchymal cells. Location, morphology,
function and role in pathology. Histol Histopathol. 29:831–870.
2014.PubMed/NCBI
|
|
29
|
Tindle RW, Nichols RA, Chan L, Campana D,
Catovsky D and Birnie GD: A novel monoclonal antibody BI-3C5
recognises myeloblasts and non-B non-T lymphoblasts in acute
leukaemias and CGL blast crises, and reacts with immature cells in
normal bone marrow. Leuk Res. 9:1–9. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Brown J, Greaves MF and Molgaard HV: The
gene encoding the stem cell antigen, CD34, is conserved in mouse
and expressed in haemopoietic progenitor cell lines, brain, and
embryonic fibroblasts. Int Immunol. 3:175–184. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Radu P, Zurzu M, Paic V, Bratucu M,
Garofil D, Tigora A, Georgescu V, Prunoiu V, Pasnicu C, Popa F, et
al: CD34-Structure, functions and relationship with cancer stem
cells. Medicina (Kaunas). 59:9382023. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Krause DS, Fackler MJ, Civin CI and May
WS: CD34: Structure, biology, and clinical utility. Blood. 87:1–13.
1996. View Article : Google Scholar : PubMed/NCBI
|
